Search results
Nov 13, 2023 · A new study by Harvard Medical School researchers at Massachusetts General Hospital and Brigham and Women’s Hospital has found that one in five individuals taking nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19 had a positive test result and shed live potentially contagious virus following an ...
Mar 25, 2024 · There have been reports of a “rebound” of COVID symptoms in some people within 2 to 8 days after completing the five-day course of Paxlovid; in those cases, some have tested positive again but have no symptoms; others have a recurrence of symptoms.
Sep 26, 2023 · While Paxlovid rebound is well documented, it’s also possible to experience a resurgence of symptoms even if you don’t take the drug. A representative from Pfizer wrote in an email that...
You can end re-isolation after 5 days if you are fever-free for. 24 hours without the use of fever-reducing medication and your symptoms are improving. You should also wear a mask for 10 days after rebound. Contact a healthcare provider if your COVID-19 rebound symptoms persist or worsen.
Dec 13, 2022 · Reports of “Paxlovid rebound” popped up in the spring of 2022, as some people who had taken the antiviral medication experienced a recurrence of Covid symptoms, days after their infection...
Jun 14, 2022 · ROCHESTER, Minn. — Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir, together marketed as Paxlovid. Only a handful developed COVID-19 rebound symptoms, and the researchers say more studies are needed to determine why.
Paxlovid treatment helps prevent hospitalization and death due to COVID-19. COVID-19 rebound has been reported to occur between 2 and 8 days after initial recovery and is characterized by a recurrence of COVID-19 symptoms or a new positive viral test after having tested negative.
